drugset / Trial / NCT00876616
Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis
Completed
362 enrolled
Zhi-Hong Liu, M.D.
Beijing Friendship Hospital · collabChina Medical University, China · collabHuashan Hospital · collabRenJi Hospital · collabRuijin Hospital · collabShanghai General Hospital, Shanghai Jiao Tong University School of Medicine · collabThe First Affiliated Hospital with Nanjing Medical University · collabWest China Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the efficacy and safety of multi-target therapy in the treatment of class Ⅲ,Ⅳ,Ⅴ,Ⅲ+Ⅴand Ⅳ+Ⅴ lupus nephritis.
Timeline
- Start
- 2009-04
- Primary completion
- 2011-05
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cyclophosphamide | Other / unclassified | 0.75 g | Intravenous |
| Subject | Mycophenolate Mofetil | Small molecule | 1 g | — |
| Subject | Tacrolimus | Small molecule | 4 mg | — |